Improving patient outcomes through novel science, art

New technology can help ophthalmologists care for their patients if they combine it with a personal touch, said Paul P. Lee, MD, JD. Find out how to improve your patient care

Retinal ganglion cell research making strides

The development of stem cell treatments for glaucoma faces big hurdles, but researchers are making rapid progress, said Yvonne Ou, MD. Click to learn more about the research

Why palliative care, support is so vital for patients who suffer vision loss

Even the best ophthalmologists must prepare to support patients who lose vision while in their care, said Robert L. Stamper, MD. Find out how best to support your patients

Economic profiling's negative impact on ophthalmic practices

Insurers are funneling patients to providers based on cost and quality data that may not always be accurate, said Ruth D. Williams, MD. Read about the negative impact on your practice

While attending the Glaucoma 360 events, stay connected by using and following
#Glaucoma360

Byers Eye Institute @ByersEye

MT Singh and Chang on the #glaucoma360 CME faculty! What a great meeting! via @nmgraydon @StanfordMed

Glaucoma Research @GlaucomaOrg

Thank you, Dr. Paul Lee of @UMKelloggEye for a fascinating CME keynote talk on improving patient care and patient outcomes. #glaucoma360.

Top Tweets

We welcome your feedback!
Please send your comments to:

Mark L. Dlugoss

Group Content Director

UBM Advanstar Eyecare Group

mdlugoss@advanstar.com

DISCLAIMER:
This information has been independently developed and provided by the editors of Ophthalmology Times.
The sponsors do not endorse and are not responsible for the accuracy of the content or for practices or standards of non-sponsor sources. These articles may discuss regimens that have not been approved by the FDA.
For full prescribing information including indications, contraindications, warnings, precautions, and adverse experiences, please see the appropriate manufacturer's product circular.

Editorial Questions? Contact the Editorial Team Click Here. Sales, Reprints, Classified questions? Contact the Sales Team Click Here.